Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Gilhar A, Ullmann Y, Berkutzki T et al (1998) Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 101:62–67
Gilhar A, Landau M, Assy B et al (2001) (2001) Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice. J Invest Dermatol 117:1357–1362
Colombe BW, Lou CD, Price VH (1999) The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J Investig Dermatol Symp Proc 4:216–219
MacDonald Hull SP, Wood ML, Hutchinson PE et al (2003) Guidelines for the management of alopecia areata. Br J Dermatol 149:692–699
Madani S, Shapiro J (2000) Alopecia areata update. J Am Acad Dermatol 42:549–566
Paus R, NickoloffBJ, Ito T (2005) A ‘hairy’ privilege. Trends Immunol 26:32–40
McElwee KJ, Boggess D, King LE Jr et al (1998) Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol 111:797–803
McElwee KJ, Freyschmidt-Paul P, Hoffmann R et al (2005) Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(−) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/ HeJ mouse model. J Invest Dermatol 124:947–957
Sundberg JP, Boggess D, Silva KA et al (2003) Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. J Invest Dermatol 120:771–775
Safavi KH, Muller SA, Suman VJ et al (1995) Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 70:628–633
Goh C, Finkel M, Christos PJ et al (2006) Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol 20:1055–1060
Olsen E, Hordinsky M, McDonald-Hull S et al (1999) Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol 40:242–246
Tosti A, Iorizzo M, Botta GL et al (2006) Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. J Eur Acad Dermatol Venereol 20:1243–1247
Olsen EA, Carson SC, Turney EA (1992) Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch Dermatol 128:1467–1473
Happle R, Hausen BM, Wiesner-Menzel L (1983) Diphencyprone in the treatment of alopecia areata. Acta Derm Venereol (Stockh) 63:49–52
Rokhsar CK, Shupack JL, Vafai JJ et al (1998) Efficacy of topical sensitizers in the treatment of alopecia areata. J Am Acad Dermatol 39:751–761
Yoshino T, Asada H, Ando Y et al (2001) Impaired responses of peripheral blood mononuclear cells to T-cell stimulants in alopecia areata patients with a poor response to topical immunotherapy. Br J Dermatol 145:415–421
Wiseman MC, Shapiro J, MacDonald N et al (2001) Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol 137:1063–1068
Tosti A, Guidetti MS, Bardazzi F et al (1996) Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis. J Am Acad Dermatol 35:199–201
Buhl AE (1991) Minoxidil's action in hair follicles. J Invest Dermatol 96 (suppl):735–745
Fiedler-Weiss VC (1987) Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata. J Am Acad Dermatol 16:745–748
Price VH (1987) Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata. J Am Acad Dermatol 16:730–736
Fiedler-Weiss VC, Buys CM (1987) Evaluation of anthralin in the treatment of alopecia areata. Arch Dermatol 123:1491–1493
Nelson DA, Spielvogel RL (1985) Anthralin therapy for alopecia areata. Int J Dermatol 24:606–607
Claudy AL, Gagnaire D (1983) PUVA treatment of alopecia areata. Arch Dermatol 119:975–978
Mitchell AJ, Douglass MC (1985) Topical photochemother-apy for alopecia areata. J Am Acad Dermatol 12:644–649
van der Schaar WW, Sillevis SJ (1984) An evaluation of PUVA-therapy for alopecia areata. Dermatologica 168:250–252
Friedli A, Labarthe MP, Engelhardt E et al (1998) Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients. J Am Acad Dermatol 39:597–602
Kar BR, Handa S, Dogra S et al (2005) Placebo-controlled oral pulse prednisolone therapy in alopecia areata. J Am Acad Dermatol 52:287–290
Nakajima T, Inui S, Itami S (2007) Pulse corticosteroid therapy for alopecia areata: study of 139 patients. Dermatology. 215:320–324
Gupta A, Ellis C, Cooper K et al (1990) Oral cyclosporine for the treatmentof alopecia areata: a clinical and immuno-histochemical analysis. J Am Acad Dermatol 22:242–250
Shapiro J, Lui H, Tron V et al (1997) Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation. J Am Acad Dermatol 36:114–117
Hay IC, Jamieson M, Ormerod AD (1998) Randomized trial of aromatherapy. Successful treatment for alopecia areata. Arch Dermatol 134:1349–1352
Ettefagh L, Nedorost S, Mirmirani P (2004) Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles. Arch Dermatol 140:1012
Posten W, Swan J (2005) Recurrence of alopecia areata in a patient receiving etanercept injections. Arch Dermatol 141:759–760
Strober BE, Siu K, Alexis AF et al (2005) Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study. J AmAcad Dermatol 52:159–163
Heffernan MP, Hurley M Y, Martin KS et al (2005) Alefacept for alopecia areata. Arch Dermatol 141:1513–1516
Kaelin U, Hassan AS, Braathen LR et al (2006) Treatment of alopecia areata partim universalis with efalizumab. J Am Acad Dermatol 55:529–532
Carnahan MC, Goldstein DA (2000) Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol 11:478–483
Alam M, Gross EA, Savin RC (1999) Severe urticarial reaction to diphenylcyclopropenonetherapy for alopecia areata. J Am Acad Dermatol 40:110–112
MacDonald Hull SP, Norris JF, Cotterill JA (1989) Vitiligo following sensitisation with diphencyprone. Br J Dermatol 120:323
Gip L, Lodin A, Molin L (1969) Alopecia areata. A follow-up investigation of outpatient material. Acta Derm Venereol (Stockh) 49:180–188
Walker SA, Rothman S (1950) Alopecia areata: a statistical study and consideration of endocrine influences. J Invest Dermatol 14:403–413
Weise K, Kretzschmar L, Jonh SM et al (1996) Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance. Dermatology 192:129–133
De Waard-van der Spek FB, Oranje AP, De Raeymaecker DM et al (1989) Juvenile versus maturity-onset alopecia areata — a comparative retrospective clinical study. Clin Exp Dermatol 14:429–433
Muller SA, Winkelmann RK (1963) Alopecia areata. Arch Dermatol 88:290–297
Tosti A, Bellavista S, Iorizzo M (2006) Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol 55:438–441
Hamilton JB (1942) Male hormone stimulation is a prerequisite and an incitant in common baldness. Am J Anatomy 71:451–480
Randall VA, Hibberts NA, Thornton MJ et al (2000) The hair follicle: a paradoxical androgen target organ. Horm Res 54:243–250
Hamada K, Thornton MJ, Laing I et al (1996) The metabolism of testosterone by dermal papilla cells cultured from human pubic and axillary hair follicles concurs with hair growth in 5 α-reductase deficiency. J Invest Dermatol 106:1017–1022
Hibberts NA, Howell AE, Randall VA (1998) Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol 156:59–65
Itami S, Kurata S, Sonoda T et al (1995) Interaction between dermal papilla cells and follicular epithelial cells in vitro. Br J Dermatol 132:527–532
Randall VA, Thornton MJ, Messenger AG (1992) Cultured dermal papilla cells from androgen-dependent human hair follicles (e.g. beard) contain more androgen receptors than those from non-balding areas of scalp. J Endocrinol 133:141–147
Thornton MJ, Laing I, Hamada K et al (1993) Differences in testosterone metabolism by beard and scalp hair follicle dermal papilla cells. Clin Endocrinol (Oxf) 39:633–639
Foitzik K, Lindner G, Mueller-Roever S et al (2000) Control of murine hair follicle regression (catagen) by TGF-β 1 in vivo. FASEB J 14:752–760
Inui S, Fukuzato Y, Nakajima T et al (2002) Androgen-inducible TGF- β 1 from balding dermal papilla cells inhibits epithelial cell growth: a clue to understand paradoxical effects of androgen on human hair growth. FASEB J 16:1967–1969
Ludwig E (1977) Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97:247–254
Norwood OT (1975) Male pattern baldness: classification and incidence. South Med J 68:1359–1365
Ross EK, Shapiro J (2005) Management of hair loss. Dermatol Clin 23:227–243
Gormley GJ, Stoner E, Rittmaster RS et al (1990) Effects of finasteride (MK-906), a 5 α -reductase inhibitor, on circulating androgens in male volunteers. J Clin Endocrinol Metab 70:1136–1141
Kawashima M, Mizoguchi M, Igarashi A et al (2006) Long term (3 years) efficucy and safety profiles of finasteride in Japanese men with AGA (androgenetic alopecia). Jpn J Clin Dermatol 60:521–530 (in Japanese)
Price VH (1999) Treatment of hair loss. N Engl J Med 341:964–973
Li M, Marubayashi A, Nakaya Y et al (2001) Minoxidil-induced hair growth is mediated by adenosine in cultured dermal papilla cells: possible involvement of sulfonylurea receptor 2B as a target of minoxidil. J Invest Dermatol 117:1594–1600
Adamopoulos DA, Karamertzanis M, Nicopoulou S et al (1997) Beneficial effect of spironolactone on androgenic alopecia. Clin Endocrinol (Oxf) 47:759–760
Peereboom-Wynia JD, van der Willigen AH, van Joost T et al (1989) The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females. Acta Derm Venereol 69:395–398
Okuda S (1939) Clinical and experimental studies of transplantation of living hairs. Jpn J Dermatol Urol 46:135–138 (in Japanese)
Inui S, Itami S (2006) Reversal of androgenetic alopecia by topical ketoconazole: relevance of anti-androgenic activity. J Dermatol Sci. doi:10.1016/j.jdermsci.2006.08.011
Iorizzo M, Vincenzi C, Voudouris S et al (2006) Finasteride treatment of female pattern hair loss. Arch Dermatol 142:298–302
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Itami, S., Inui, S. (2010). Hair Diseases (Alopecia Areata and Androgenetic Alopecia). In: Krieg, T., Bickers, D.R., Miyachi, Y. (eds) Therapy of Skin Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78814-0_44
Download citation
DOI: https://doi.org/10.1007/978-3-540-78814-0_44
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78813-3
Online ISBN: 978-3-540-78814-0
eBook Packages: MedicineMedicine (R0)